CSF3 and Sepsis: G-CSF has been included in clinical trials for the prophylaxis and treatment of sepsis [28,29], while monocyte chemotactic protein-1 may be involved in the pathophysiology of sepsis as plasma levels of this chemokine are elevated in septic patients [30], but its role remains controversial [31,32].